And today we are talking about lifestyle medicine, weight loss, and medication as part of both of those components, and particularly the GLP-1 receptor agonist medications
Pregnant, breastfeeding, or kidney/liver patients should avoid this treatment
Two are still open: TRIUMPH-7 (NCT07035093), for obesity or overweight with chronic low back pain, and the Phase 3 multi-agent MASLD master protocol (NCT07165028), which studies several drugs rather than retatrutide alone
Medication Reviews: Periodically review all your medications with your healthcare provider to ensure that there are no interactions that could be contributing to your fast heart rate
2022 Apr 28;: PMID: 35316513
Do not discontinue Wegovy without medical guidance unless you suspect a serious adverse reaction such as pancreatitis, as abrupt cessation may affect weight management goals and metabolic control